Consistent with these findings, another in vivo study using a rat model of nicotinamide- and STZ-induced T2DM demonstrated that oral p-coumaric acid administration (40 mg/kg body weight) significantly improved glycemic control, enhanced insulin secretion, and increased body weight while reducing glucose and HbA1c levels [142]. The gene discussed is INS; the disease is type 2 diabetes mellitus.